v3.25.4

BUSINESS COMBINATION AGREEMENT WITH POWERUP ACQUISITON CORP (Details Narrative) $ in Millions | Dec. 31, 2024 USD ($)
--- | ---
Aspire Biopharma Inc [Member] |
Transaction costs | $ 316.8

X
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7 + Details
Name: | us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ASBP_AspireBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |